Bill Title: Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.

Spectrum: Partisan Bill (Democrat 4-0)

Status: (Introduced) 2024-05-15 - REPORTED AND COMMITTED TO FINANCE [S04513 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
Introduced	2023-02-09	HTML/Text	Link	View

Amendments

Amendment	Date	Disposition	Format	Source	View
No bill amendments currently on file for New York S04513

Supplemental Documents

Title	Description	Date	Format	Source	View
No supplemental documents for New York S04513 currently on file.

Social Comments on NY S04513